다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The Korean journal of internal medicine : KJIM, v.33 no.2, 2018년, pp.247 - 255
Kim, Young Ah (Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea) , Park, Yoon Soo (Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea)
AI-Helper
Antimicrobial resistance is becoming one of the greatest challenges to public health worldwide. Infections by antimicrobial-resistant organisms could result in the failure of treatment, increased medical costs, prolonged hospital stays, and an increased socioeconomic burden. Antimicrobial usage in K...
1 Martin-Loeches I Diaz E Valles J Risks for multidrug-resistant pathogens in the ICU Curr Opin Crit Care 2014 20 516 524 25188366
2 Yoon YK Park GC An H Chun BC Sohn JW Kim MJ Trends of antibiotic consumption in Korea according to national reimbursement data (2008-2012): a population-based epidemiologic study Medicine (Baltimore) 2015 94 e2100 26579825
3 Kim DS Jang SM Kim NS Epidemiologic investigation on antibiotic use using defined daily dose J Korean Acad Manag Care Pharm 2010 2 47 59
4 Lee Y Kim YA Song W Recent trends in antimicrobial resistance in intensive care units in Korea Korean J Nosocomial Infect Control 2014 19 29 36
5 Abbasi J Infectious disease expert sees threat from colistin-resistant superbug JAMA 2016 316 806 807 27464338
6 Ryu S The new Korean action plan for containment of antimicrobial resistance J Glob Antimicrob Resist 2017 8 70 73 28024981
7 Kim D Ahn JY Lee CH Increasing resistance to extended-spectrum cephalosporins, fluoroquinolone, and carbapenem in gram-negative bacilli and the emergence of carbapenem non-susceptibility in Klebsiella pneumoniae: analysis of Korean Antimicrobial Resistance Monitoring System (KARMS) data from 2013 to 2015 Ann Lab Med 2017 37 231 239 28224769
8 Cai Y Chai D Wang R Liang B Bai N Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies J Antimicrob Chemother 2012 67 1607 1615 22441575
9 Kim EJ Kwak YG Park SH Trends of device utilization ratios in intensive care units over 10-year period in South Korea: device utilization ratio as a new aspect of surveillance J Hosp Infect 2017
10 Yong D Shin HB Kim YK Increase in the prevalence of carbapenem-resistant Acinetobacter isolates and ampicillin-resistant non-typhoidal salmonella species in Korea: a KONSAR Study conducted in 2011 Infect Chemother 2014 46 84 93 25024870
11 World Health Organization Global antimicrobial resistance surveillance system [Internet] Geneva World Health Organization c2018 [cited 2018 Feb 8]. Available from: http://www.who.int/antimicrobial-resistance/publications/surveillance-system-manual/en/
12 Jasemi S Douraghi M Adibhesami H Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period Lett Appl Microbiol 2016 63 466 472 27626896
13 Moon SY Peck KR Chang HH Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp Microb Drug Resist 2012 18 562 566 22775562
14 Johnson JR Johnston B Clabots C Kuskowski MA Castanheira M Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States Clin Infect Dis 2010 51 286 294 20572763
15 Rogers BA Sidjabat HE Paterson DL Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain J Antimicrob Chemother 2011 66 1 14 21081548
16 Kim SY Park YJ Johnson JR Yu JK Kim YK Kim YS Prevalence and characteristics of Escherichia coli sequence type 131 and its H30 and H30Rx subclones: a multicenter study from Korea Diagn Microbiol Infect Dis 2016 84 97 101 26643062
17 Kim H Kim YA Park YS Choi MH Lee GI Lee K Risk factors and molecular features of sequence type (ST) 131 extended-spectrum β-lactamase-producing Escherichia coli in community-onset bacteremia Sci Rep 2017 7 14640 29116143
18 Kim YA Kim JJ Kim H Lee K Community-onset extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 at two Korean community hospitals: the spread of multidrug-resistant E. coli to the community via healthcare facilities Int J Infect Dis 2017 54 39 42 27865830
19 Johnson JR Tchesnokova V Johnston B Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli J Infect Dis 2013 207 919 928 23288927
20 DSouza R Pinto NA Hwang I Molecular epidemiology and resistome analysis of multidrug-resistant ST11 Klebsiella pneumoniae strain containing multiple copies of extended-spectrum β-lactamase genes using whole-genome sequencing New Microbiol 2017 40 38 44 28072891
21 Wachino J Arakawa Y Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update Drug Resist Updat 2012 15 133 148 22673098
22 Pfeifer Y Cullik A Witte W Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens Int J Med Microbiol 2010 300 371 379 20537585
23 Bauernfeind A Chong Y Schweighart S Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins Infection 1989 17 316 321 2689349
24 Queenan AM Bush K Carbapenemases: the versatile beta-lactamases Clin Microbiol Rev 2007 20 440 458 17630334
25 Bonomo RA Burd EM Conly J Carbapenemase-producing organisms: a global scourge! Clin Infect Dis 2017
26 Lee HJ Choi JK Cho SY Carbapenem-resistant enterobacteriaceae: prevalence and risk factors in a single community-based hospital in Korea Infect Chemother 2016 48 166 173 27659436
27 Kim MN Yong D An D Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital J Clin Microbiol 2012 50 1433 1436 22259206
28 Jeong SH Lee KM Lee J Clonal and horizontal spread of the blaOXA-232 gene among Enterobacteriaceae in a Korean hospital Diagn Microbiol Infect Dis 2015 82 70 72 25702524
29 Hong SK Yong D Kim K First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea J Clin Microbiol 2013 51 3877 3879 24006005
30 Kim YA Park YS Youk T Lee H Lee K Abrupt increase in rate of imipenem resistance in Acinetobacter baumannii complex strains isolated from general hospitals in Korea and correlation with carbapenem administration during 2002-2013 Ann Lab Med 2018 38 179 181 29214766
31 Lee Y Kim YR Kim J Increasing prevalence of bla-OXA-23-carrying Acinetobacter baumannii and the emergence of blaOXA-182-carrying Acinetobacter nosocomialis in Korea Diagn Microbiol Infect Dis 2013 77 160 163 23891219
32 Doi Y Murray GL Peleg AY Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options Semin Respir Crit Care Med 2015 36 85 98 25643273
33 Lee K Lim JB Yum JH bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital Antimicrob Agents Chemother 2002 46 1053 1058 11897589
34 Hong DJ Bae IK Jang IH Jeong SH Kang HK Lee K Epidemiology and characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa Infect Chemother 2015 47 81 97 26157586
35 Kim YA Park YS Youk T Lee H Lee K Correlation of aminoglycoside consumption and amikacin- or gentamicin-resistant Pseudomonas aeruginosa in long-term nationwide analysis: is antibiotic cycling an effective policy for reducing antimicrobial resistance? Ann Lab Med 2018 38 176 178 29214765
36 Almaghrabi R Clancy CJ Doi Y Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents Antimicrob Agents Chemother 2014 58 4443 4451 24867988
37 Lemos EV de la Hoz FP Einarson TR Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis Clin Microbiol Infect 2014 20 416 423 24131374
38 Lee NY Lee HC Ko NY Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia Infect Control Hosp Epidemiol 2007 28 713 719 17520546
39 Lee H Lee H Clinical and economic evaluation of multidrug-resistant Acinetobacter baumannii colonization in the intensive care unit Infect Chemother 2016 48 174 180 27659440
40 Batirel A Balkan II Karabay O Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections Eur J Clin Microbiol Infect Dis 2014 33 1311 1322 24532009
41 Shields RK Clancy CJ Gillis LM Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients PLoS One 2012 7 e52349 23285002
42 Tzouvelekis LS Markogiannakis A Piperaki E Souli M Daikos GL Treating infections caused by carbapenemase-producing Enterobacteriaceae Clin Microbiol Infect 2014 20 862 872 24890393
43 Falagas ME Lourida P Poulikakos P Rafailidis PI Tansarli GS Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence Antimicrob Agents Chemother 2014 58 654 663 24080646
44 Falagas ME Kasiakou SK Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin Infect Dis 2005 40 1333 1341 15825037
45 Nation RL Velkov T Li J Colistin and polymyxin B: peas in a pod, or chalk and cheese? Clin Infect Dis 2014 59 88 94 24700659
46 Kassamali Z Danziger L To B or not to B, that is the question: is it time to replace colistin with polymyxin B? Pharmacotherapy 2015 35 17 21 25346395
47 Roberts JA Kirkpatrick CM Roberts MS Robertson TA Dalley AJ Lipman J Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution J Antimicrob Chemother 2009 64 142 150 19398460
48 MacVane SH Kuti JL Nicolau DP Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation Int J Antimicrob Agents 2014 43 105 113 24359838
49 Qureshi ZA Paterson DL Potoski BA Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens Antimicrob Agents Chemother 2012 56 2108 2113 22252816
50 Lopez-Cortes LE Cisneros JM Fernandez-Cuenca F Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort J Antimicrob Chemother 2014 69 3119 3126 24970742
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.